Provider Tools

Recommended resources from across the SRH field
Latest Edition

Using ASA Cycles to respond to mis/disinformation

Let’s switch it up: Changing OCP formulations to address side effects

Practical strategies for adjusting combined oral contraceptive formulations to manage side effects and improve patient experiences

Misinformation vs. disinformation in the exam room

Patients are seeing misinformation and disinformation online; here’s how to spot the difference and respond with clarity.

Clinical scenario: Pregnancy of unknown location & abortion care

A 21 year-old individual (they/them) presents requesting a medication abortion. Their LMP was five weeks ago. They had a positive home pregnancy test three days ago, confirmed in clinic. Transvaginal ultrasound shows no visible intrauterine pregnancy (no gestational sac or yolk sac) and no signs of ectopic pregnancy. They deny pelvic pain, bleeding, or spotting since their LMP.

Pharmacist Administration of DMPA

Expanding Access to Injectable Contraception through Community Pharmacies

2024 Updates to the U.S. SPR and U.S. MEC

New and updated guidance on the initiation and management of contraception, including pain management options for IUD placement, support for DMPA-SQ, and new conditions and methods added.

Does the route of misoprostol matter?

Answers for healthcare providers on routes of misoprostol administration and what they mean for medication abortion care.
  • Previous
  • 1(current)
  • 2
  • 3
  • Next